|
|
Volumn 376, Issue 9747, 2010, Pages 1117-
|
|
Cancer: The revolution has begun
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BRCA1 PROTEIN;
CABAZITAXEL;
MITOXANTRONE;
RITUXIMAB;
TAMOXIFEN;
TAXANE DERIVATIVE;
TRASTUZUMAB;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR;
BREAST CANCER;
CANCER GENETICS;
CANCER RESEARCH;
CANCER SURVIVAL;
CHROMOSOME 11Q;
CHROMOSOME 17P;
CHRONIC LYMPHATIC LEUKEMIA;
EDITORIAL;
GENE DELETION;
HUMAN;
LUNG NON SMALL CELL CANCER;
OVARY CANCER;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROSTATE CANCER;
BREAST NEOPLASMS;
CHROMOSOME 11;
CHROMOSOME 17;
EUROPEAN UNION;
FEMALE;
GENETICS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
MUTATION;
NEOPLASMS;
OVARIAN NEOPLASMS;
PERSONALIZED MEDICINE;
RNA INTERFERENCE;
SURVIVAL;
TRENDS;
UNITED KINGDOM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHROMOSOMES, HUMAN, PAIR 11;
CHROMOSOMES, HUMAN, PAIR 17;
EUROPEAN UNION;
FEMALE;
GENE DELETION;
GREAT BRITAIN;
HUMANS;
INDIVIDUALIZED MEDICINE;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
MUTATION;
NEOPLASMS;
OVARIAN NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RNA INTERFERENCE;
SURVIVAL ANALYSIS;
|
|
EID: 84928585130
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(10)61518-8 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|